Qiagen N.V. Common Shares (QGEN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Qiagen N.V. Common Shares (QGEN) is Neutral.

The composite score behind that read is +0.06, weighing +0.21 of bullish evidence against -0.18 bearish.

Qiagen N.V. Common Shares last closed at $45.38, +1.91% on the session.

Against the IVW growth benchmark the position is +1.11% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

Qiagen N.V. Common Shares has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Qiagen N.V. Common Shares in the 41st percentile on valuation and the 65th percentile on return on equity, where 100 is best.

Qiagen N.V. Common Shares is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $9.20B.

StockMap tracks Qiagen N.V. Common Shares as the 18th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Qiagen N.V. Common Shares ranks 24th of 41 in the group, against a group median of +0.06.